Lapatinib (GW572016): Mechanism of Action

Lapatinib (GW572016) MOA:Targeting HER2/EGFR Pathway for HER2-Positive Breast Cancer

🎯 check Lapatinib (GW572016) product page

Lapatinib (GW572016) is a potent, reversible dual EGFR and HER2 tyrosine kinase inhibitor. It affects PI3K/AKT/mTOR and MAPK/ERK signaling pathways by blocking receptor autophosphorylation, inhibiting tumor cell proliferation and promoting apoptosis.

Primary Applications and Mechanism of Action